Apogee Therapeutics, Inc. (APGE) Revenue History
Annual and quarterly revenue from 2022 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
APGE Revenue Analysis (2022–2024)
As of February 28, 2026, Apogee Therapeutics, Inc. (APGE) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, APGE's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ARGX (+335.2% YoY), CANF (-16.0% YoY), and ABVX (+125.1% YoY). Compare APGE vs ARGX →
Peer Comparison
Compare APGE's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| APGECurrent | $0 | - | - | - | |
| ARGX | $2.2B | +335.2% | +94.6% | -1.0% | |
| CANF | $674,000 | -16.0% | -19.8% | -1206.2% | |
| ABVX | $11M | +125.1% | +457.7% | -1602.9% | |
| KYMR | $39M | -16.7% | +2.9% | -891.3% | |
| TGTX | $329M | +31.0% | +364.6% | 12.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-216,870,000 | - |
| 2023 | $0 | - | $0 | - | $-93,003,000 | - |
| 2022 | $0 | - | $0 | - | $-30,727,000 | - |
See APGE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs APGE Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare APGE vs AGIO
See how APGE stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is APGE's revenue growth accelerating or slowing?
APGE TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is APGE's long-term revenue growth rate?
Apogee Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is APGE's revenue distributed by segment?
APGE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2024 are available for download. Segment mix reveals concentration and diversification trends.